Administration Boosts Clean Energy with $4 Billion Loan Guarantee Program
Client Alert | 1 min read | 07.07.14
On July 3, the Department of Energy announced the issuance of Solicitation No. DE-SOL-0007154, "Loan Guarantee Solicitation for Applications for Renewable Energy Projects and Efficient Energy Projects," under which DOE will make up to $4 billion in loan guarantees available to entities developing renewable energy and energy efficiency projects and technologies in the U.S., the latest effort by the Obama Administration to stimulate investment in advanced energy technologies that reduce or avoid anthropogenic greenhouse gas emissions (discussed previously here and here). The new DOE offering is focused on providing loan guarantees to qualifying projects in "five key technology areas," including smart grid systems, clean power production with energy storage, biorefineries, advanced waste-to-energy conversion, and end-use efficiency improvements, among others, and joins two other DOE programs now accepting applications, the $8 billion Advanced Fossil Energy Projects solicitation and the $16 billion Advanced Technology Vehicle Manufacturing loan program.
Contacts
Insights
Client Alert | 3 min read | 04.17.26
On March 18, 2026, the Antitrust Division (Division) of the U.S. Department of Justice (DOJ) entered into a Non-Prosecution Agreement (“NPA”) with Broadway Across America (“BAA”), resolving a criminal antitrust investigation into agreements between BAA and another entertainment company (“Company A”) that included non-compete restrictions on Company A’s ability to offer potentially competing programming. Notably, the restrictions were contained in a vertical agreement by which BAA presented touring shows at theaters owned by Company A. The announcement is a reminder that the agencies continue to scrutinize non-compete agreements contained in business contracts, and all non-compete provisions, even those included between vertical partners, should be reviewed by antitrust counsel.
Client Alert | 2 min read | 04.16.26
Client Alert | 4 min read | 04.16.26
ROI Tracking as Mens Rea? Novartis Ruling Reframes AKS Pleading Risk
Client Alert | 4 min read | 04.15.26

